Product Details

Cefexiclav Powder for Oral Suspension 50 mg/31.25 mg/5 mL##

Cefixime; Clavulanic Acid (Clavulanate Potassium)
50 mg/5 mL; 31.25 mg/5 mL
Suspension

ROA

Oral

Applicant Name

SJS Life Sciences Limited

NRN

B4-6583

Status

Active


Composition

Each 5 mL of reconstituted suspension contains: Cefixime BP (As Trihydrate) equivalent to Anhydrous Cefixime 50 mg, Clavulanate Potassium BP equivalent to Anhydrous Clavulanic Acid 31.25 mg Excipients q.s.  

ATC Code

J01DD08  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 100 mL (in HDPE bottle)  

Product Description

Powder for Oral Suspension 149 CMS-PP-233255 CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML CEFIXIME 50MG + CLAVULANIC ACID 31.25MG Cefixime Trihydrate Eq to Cefixime (A) 50mg, Diluted Potassium Clavulanate Eq. to Clavulanic Acid (A) 31.25mg, Sucrose (D)$ 937mg, Colloidal Anhydrous Silica 15mg, Carmellose Sodium (Sodium Carboxymethylcellulose) 25mg, Sodium Citrate 11.25mg, Sodium Benzoate 1.04mg, Essence Orange Powder (Firemenich) 13.10mg, Aspartame 6.360mg, Disodium Edetate 10mg B4-6583 Drugs Imported Products 1*100ML Prescription Only Medicine (POM) 10/5/2021 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India

Manufacturer Name

Globela Pharma Pvt Ltd

Manufacturer Country

INDIA  

Approval Date

2023-07-06  

Expiry Date

2028-07-05